AI English summary of an SEC filing — figures as filed
Zimmer Biomet ZBHThe company said its Board of Directors increased the size of the Board from 10 members to 11 members and appointed Louis A. Shapiro to fill the resulting vacancy on January 5, 2024. His term expires at the 2024 annual meeting of shareholders.
Key points
AI summaryThe company said its Board of Directors increased the size of the Board from 10 members to 11 members and appointed Louis A. Shapiro to fill the resulting vacancy on January 5, 2024. His term expires at the 2024 annual meeting of shareholders.
The company said Mr. Shapiro was assigned to the Audit Committee and the Quality, Regulatory and Technology Committee. It added that there are no arrangements or understandings with any other person related to his appointment, and that he has no material interest in any transaction subject to disclosure under Item 404(a).
The company said Mr. Shapiro joined Hospital for Special Surgery (HSS) as President and Chief Executive Officer in October 2006 and retired in October 2023. Before that, he worked at Geisinger Health System and McKinsey & Co.
The company said Mr. Shapiro will participate in the non-employee director compensation arrangements described in the proxy statement filed on March 30, 2023, and is expected to sign the company's standard non-employee director indemnification agreement.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Board Expands From 10 to 11 Members
The company said its Board of Directors increased the size of the Board from 10 members to 11 members and appointed Louis A. Shapiro to fill the resulting vacancy on January 5, 2024. His term expires at the 2024 annual meeting of shareholders.
Source · Based on the filing body and exhibits
Shapiro Named to Board Committees
The company said Mr. Shapiro was assigned to the Audit Committee and the Quality, Regulatory and Technology Committee. It added that there are no arrangements or understandings with any other person related to his appointment, and that he has no material interest in any transaction subject to disclosure under Item 404(a).
Source · Based on the filing body and exhibits
Shapiro's Career Background
The company said Mr. Shapiro joined Hospital for Special Surgery (HSS) as President and Chief Executive Officer in October 2006 and retired in October 2023. Before that, he worked at Geisinger Health System and McKinsey & Co.
Source · Based on the filing body and exhibits
Non-Employee Director Compensation and Indemnification
The company said Mr. Shapiro will participate in the non-employee director compensation arrangements described in the proxy statement filed on March 30, 2023, and is expected to sign the company's standard non-employee director indemnification agreement.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…